Oregon Administrative Rules
Chapter 855 - BOARD OF PHARMACY
Division 20 - PHARMACIST PRESCRIPTIVE AUTHORITY
Section 855-020-0300 - Protocol Compendium

Universal Citation: OR Admin Rules 855-020-0300

Current through Register Vol. 63, No. 3, March 1, 2024

A Pharmacist may prescribe, via statewide drug therapy management protocol and according to rules outlined in this Division, an FDA-approved drug and device listed in the following compendium:

(1) Continuation of therapy including emergency refills of insulin (v. 06/2023)

(2) Conditions

(a) Cough and cold symptom management
(A) Pseudoephedrine (v. 06/2021);

(B) Benzonatate (v. 06/2021);

(C) Short-acting beta agonists (v. 06/2021);

(D) Intranasal corticosteroids (v. 06/2021);

(b) Vulvovaginal candidiasis (VVC) (v. 06/2021);

(c) COVID-19 Antigen Self-Test (v. 12/2021);

(3) Preventative care

(a) Emergency Contraception (v. 06/2021);

(b) Male and female condoms (v. 06/2021);

(c) Tobacco Cessation, NRT (Nicotine Replacement Therapy) and Non-NRT (v. 06/2022);

(d) Travel Medications (v. 06/2023);

(e) HIV Post-exposure Prophylaxis (PEP) (v. 06/2023);

(f) HIV Pre-exposure Prophylaxis (PrEP) (v. 06/2023); and

(g) Contraception (v. 06/2023).

Publications referenced are available from the agency.

Statutory/Other Authority: ORS 689.205

Statutes/Other Implemented: ORS 689.645, ORS 689.649, ORS 689.689 & ORS 689.696

Disclaimer: These regulations may not be the most recent version. Oregon may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.